Agonist-induced internalization of kappa-opioid receptors in noradrenergic neurons of the rat locus coeruleus

Journal of Chemical Neuroanatomy

Volumn 40, Issue 4, 2010, Pages 301-309

  Reyes, B A S ^a   Chavkin, Charles ^b   Van Bockstaele, E J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

OR; Dopamine beta hydroxylase; Electron microscopy; U50,488

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE;

ARTICLE; CELL MEMBRANE; LOCUS CERULEUS; MALE; NERVE CELL; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; DOPAMINE BETA-HYDROXYLASE; ENDOCYTOSIS; ENKEPHALINS; LOCUS COERULEUS; MALE; MICROSCOPY, IMMUNOELECTRON; NEURONS; NOREPINEPHRINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 78449275714     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.09.003     Document Type: Article

References (71)

1. Ackley M.A., Hurley R.W., Virnich D.E., Hammond D.L. A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 2001, 91:377-388.
2. Aston-Jones G., Foote S.L., Bloom F.E. Anatomy and physiology of locus coeruleus neurons: functional implications. Norepinephrine (Frontiers of Clinical Neuroscience) 1984, 92-116. Williams and Wilkins, Baltimore. M. Ziegler, C.R. Lake (Eds.).
3. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., Van Bockstaele E.J., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 1991, 88:47-75.
4. Aston-Jones G., Zhu Y., Card J.P. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J. Neurosci. 2004, 24:2313-2321.
5. Bajic D., Proudfit H.K., Van Bockstaele E.J. Periaqueductal gray neurons monosynaptically innervate extranuclear noradrenergic dendrites in the rat pericoerulear region. J. Comp. Neurol. 2000, 427:649-662.
6. Beardsley P.M., Howard J.L., Shelton K.L., Carroll F.I. Differential effects of the novel kappa opioid receptor antagonist JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl.) 2005, 183:118-126.
7. Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003, 42:33-84.
8. Bruchas M.R., Land B.B., Aita M., Xu M., Barot S.K., Li S., Chavkin C. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J. Neurosci. 2007, 27:11614-11623.
9. Carlezon W.A., Beguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., Cohen B.M. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 2006, 316:440-447.
10. Chan J., Aoki C., Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Methods 1990, 33:113-127.
11. Chu P., Murray S., Lissin R.D., von Zastrow M. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 1997, 272:27124-27130.
12. Devauges V., Sara S.J. Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav. Brain Res. 1990, 39:19-28.
13. Drake C.T., Chavkin C., Milner T.A. Kappa opioid receptor-like immunoreactivity is present in substance P-containing subcortical afferents in guinea pig dentate gyrus. Hippocampus 1997, 7:36-47.
14. Drake C.T., De Oliveira A.X., Harris J.A., Connor D.M., Winkler C.W., Aicher S.A. Kappa opioid receptors in the rostral ventromedial medulla of male and female rats. J. Comp. Neurol. 2007, 500:465-476.
15. Drake C.T., Patterson T.A., Simmons M.L., Chavkin C., Milner T.A. Kappa opioid receptor-like immunoreactivity in guinea pig brau ltrastructural localization in presynaptic terminals in hippocampal formation. J. Neurol. Comp. 1996, 370:377-395.
16. Endoh T., Matsuura H., Tanaka C., Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch. Int. Pharmacodyn. Ther. 1992, 316:30-42.
17. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 2001, 53:1-24.
18. Finch A.R., Caunt C.J., Armstrong S.P., McArdle C.A. Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors. Am. J. Physiol. Cell Physiol. 2009, 297:C591-600.
19. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 1983, 63:844-914.
20. Ford C.P., Beckstead M.J., Williams J.T. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J. Neurophysiol. 2007, 97:883-891.
21. Grant S.J., Aston-Jones G., Redmond D.E. Responses of primate locus coeruleus neurons to simple and complex sensory stimuli. Brain Res. Bull. 1988, 21:401-410.
22. Halasy K., Racz B., Maderspach K. Kappa opioid receptors are expressed by interneurons in the CA1 area of the rat hippocampus: a correlated light and electron microscopic immunocytochemical study. J. Chem. Neuroanat. 2000, 19:233-241.
23. Harris J.A., Chang P.C., Drake C.T. Kappa opioid receptors in rat spinal cord: sex-linked distribution differences. Neuroscience 2004, 124:879-890.
24. Jordan B.A., Cvejic S., Devi L.A. Kappa opioid receptor endocytosis by dynorphin peptides. DNA Cell Biol. 2000, 19:19-27.
25. Kreibich A.S., Reyes B.A.S., Curtis A.L., Ecke L., Chavkin C., Van Bockstaele E.J., Valentino R.J. Presynaptic inhibition of diverse afferents to the locus coeruleus by kappa opiate receptors: a novel mechanism for regulating the central norepinephrine system. J. Neurosci. 2008, 28:6516-6525.
26. Laorden M.L., Milanes M.V. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. Life Sci. 2000, 66:803-815.
27. Law P.Y., Hom D.S., Loh H.H. Loss of opiate receptor activity in neuroblastoma×glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Mol. Pharmacol. 1982, 22:1-4.
28. Lefkowitz R.J. G protein-coupled receptors III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 1998, 273:18677-18680.
29. Leranth C., Pickel V.M. Electron microscopic preembedding double-labeling methods. Neuroanatomical Tracing Methods, vol. 2 1989, 129-172. Plenum Press, New York. L. Heimer, L. Zaborszky (Eds.).
30. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8:1488-1500.
31. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens W.C., Jones R.M., Portoghese P.S., Carlezon W.A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 2003, 305:323-330.
32. Mansour A., Fox C.A., Meng F., Akil H., Watson S.J. Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 1994, 5:124-144.
33. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci. 2003, 23:5674-5683.
34. McLaughlin J.P., Xu M., Mackie K., Chavkin C. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J. Biol. Chem. 2003, 278:34631-34640.
35. Oropeza V.C., Mackie K., Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 2007, 1127:36-44.
36. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Elsevier Academic Press, New York.
37. Peters A., Palay S.L. The morphology of synapses. J. Neurocytol. 1996, 25:687-700.
38. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 1986, 233:774-776.
39. Puttfarcken P.S., Werling L.L., Cox B.M. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Mol. Pharmacol. 1988, 33:520-527.
40. Rasmussen K., Strecker R.E., Jacobs B.L. Single unit response of noradrenergic, serotonergic and dopaminergic neurons in freely moving cats to simple sensory stimuli. Brain Res. 1986, 369:336-340.
41. Redila V.A., Chavkin C. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl.) 2008, 200:59-70.
42. Reece P.A., Sedman A.J., Rose S., Wright D.S., Dawkins R., Rajagopalan R. Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans. J. Clin. Pharmacol. 1994, 34:1126-1132.
43. Reyes B.A.S., Chavkin C., Van Bockstaele E.J. Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus. J. Comp. Neurol. 2009, 512:419-431.
44. Reyes B.A.S., Drolet G., Van Bockstaele E.J. Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents. J. Comp. Neurol. 2008, 508:663-675.
45. Reyes B.A.S., Fox K., Valentino R.J., Van Bockstaele E.J. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur. J. Neurosci. 2006, 23:2991-2998.
46. Reyes B.A.S., Johnson A.D., Glaser J.D., Commons K.G., Van Bockstaele E.J. Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus. Neuroscience 2007, 145:1077-1086.
47. Reyes B.A.S., Valentino R.J., Van Bockstaele E.J. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008, 149:122-130.
48. Sara S.J., Dyon-Laurent C., Herve A. Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system. Brain Res. Cogn. Brain Res. 1995, 2:181-187.
49. Shannon H.E., Eberle E.L., Mitch C.H., McKinzie D.L., Statnick M.A. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats. Neuropharmacology 2007, 53:930-941.
50. Shipley M.T., Fu L., Ennis M., Liu W.L., Aston-Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 1996, 365:56-68.
51. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem. 2004, 90:1258-1268.
52. Simmons M.L., Chavkin C. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol. Pharmacol. 1996, 50:80-85.
53. Sullivan G.M., Coplan J.D., Kent J.M., Gorman J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol. Psychiatry 1999, 46:1205-1218.
54. Svingos A.L., Colago E.E. Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex. Brain Res. 2002, 946:262-271.
55. Svingos A.L., Colago E.E., Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 1999, 19:1804-1813.
56. Swanson L.W. The locus coeruleus: a cytoarchitectonic Golgi and immunohistochemical study in the albino rat. Brain Res. 1976, 110:39-56.
57. Swanson L.W. Brain Maps: Structure of the Rat Brain 1992, Elsevier, New York.
58. Tokuyama S., Zhu H., Wakabayashi H., Feng Y.Z., Ho I.K. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. J. Biomed. Sci. 1998, 5:45-53.
59. Valdez G.R., Platt D.M., Rowlett J.K., Ruedi-Bettschen D., Spealman R.D. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J. Pharmacol. Exp. Ther. 2007, 323:525-533.
60. Valentino R.J., Van Bockstaele E.J. Functional interactions between stress neuromediators and the locus-coeruleus noradrenaline system. Handbood of Stress and the Brain 2005, 465-486. Elsevier, Amsterdam. T.K.N. Steckler, J.M.H.M. Reul (Eds.).
61. Van Bockstaele E.J., Colago E.E.O., Moriwaki A., Uhl G.R. Mu-opioid receptor is located on the plasma membrane of dendrites that receive asymmetric synapses from axon terminals containing leucine-enkephalin in the rat nucleus locus coeruleus. J. Comp. Neurol. 1996, 376:65-74.
62. Van Bockstaele E.J., Commons K.G. Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus. Neuroscience 2001, 108:466-477.
63. Van Bockstaele E.J., Pickel V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol. 1993, 334:603-617.
64. Van Bockstaele E.J., Reyes B.A.S., Valentino R.J. The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res. 2010, 1314:162-174.
65. Walsh S.L., Strain E.C., Abreu M.E., Bigelow G.E. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl.) 2001, 157:151-162.
66. Wang X., Dergacheva O., Griffioen K.J., Huang Z.G., Evans C., Gold A., Bouairi E., Mendelowitz D. Action of kappa and delta opioid agonists on premotor cardiac vagal neurons in the nucleus ambiguus. Neuroscience 2004, 129:235-241.
67. Wang Y., Chen Y., Xu W., Lee D.Y., Ma Z., Rawls S.M., Cowan A., Liu-Chen L.Y. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A. J. Pharmacol. Exp. Ther. 2008, 324:1073-1083.
68. Wang Y., Xu W., Huang P., Chavkin C., Van Bockstaele E.J., Liu-Chen L.Y. Effects of acute agonist treatment on subcellular distribution of kappa opioid receptor in rat spinal cord. J. Neurosci. Res. 2009, 87:1695-1702.
69. Werling L.L., McMahon P.N., Cox B.M. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. J. Pharmacol. Exp. Ther. 1988, 247:1103-1106.
70. Yu S.S., Lefkowitz R.J., Hausdorff W.P. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J. Biol. Chem. 1993, 268:337-341.
71. Zhu M.Y., Klimek V., Dilley G.E., Haycock J.W., Stockmeier C., Overholser J.C., Meltzer H.Y., Ordway G.A. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol. Psychiatry 1999, 46:1275-1286.